219 related articles for article (PubMed ID: 28781201)
1. Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder.
Frosini D; Cosottini M; Donatelli G; Costagli M; Biagi L; Pacchetti C; Terzaghi M; Cortelli P; Arnaldi D; Bonanni E; Tosetti M; Bonuccelli U; Ceravolo R
Parkinsonism Relat Disord; 2017 Oct; 43():105-109. PubMed ID: 28781201
[TBL] [Abstract][Full Text] [Related]
2. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
[TBL] [Abstract][Full Text] [Related]
3. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the substantia nigra echogenicity and
Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
[TBL] [Abstract][Full Text] [Related]
5. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
6. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
[TBL] [Abstract][Full Text] [Related]
7. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
[TBL] [Abstract][Full Text] [Related]
8. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
9. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
[TBL] [Abstract][Full Text] [Related]
10. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
[TBL] [Abstract][Full Text] [Related]
11. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
[TBL] [Abstract][Full Text] [Related]
13. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.
Kim YK; Yoon IY; Kim JM; Jeong SH; Kim KW; Shin YK; Kim BS; Kim SE
Eur J Neurol; 2010 Mar; 17(3):487-92. PubMed ID: 19968708
[TBL] [Abstract][Full Text] [Related]
14. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
[TBL] [Abstract][Full Text] [Related]
15. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
[TBL] [Abstract][Full Text] [Related]
16. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
17. Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT.
Unger MM; Möller JC; Stiasny-Kolster K; Mankel K; Berg D; Walter U; Hoeffken H; Mayer G; Oertel WH
Mov Disord; 2008 Mar; 23(4):596-9. PubMed ID: 18175346
[TBL] [Abstract][Full Text] [Related]
18. Symmetric and Profound Monoaminergic Degeneration in Parkinson's Disease with Premotor REM Sleep Behavior Disorder.
Woo KA; Kim HJ; Shin JH; Cho K; Choi H; Jeon B
J Parkinsons Dis; 2024; 14(4):823-831. PubMed ID: 38640171
[TBL] [Abstract][Full Text] [Related]
19. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
[TBL] [Abstract][Full Text] [Related]
20. Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD.
Arnaldi D; Morbelli S; Brugnolo A; Girtler N; Picco A; Ferrara M; Accardo J; Buschiazzo A; de Carli F; Pagani M; Nobili F
Parkinsonism Relat Disord; 2016 Aug; 29():47-53. PubMed ID: 27264343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
